SEC Form 4 · accession 0001209191-15-056301
Alexza Pharmaceuticals Inc. · ALXA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deepika Pakianathan
Director
Period of report
Jun 23, 2015
Accepted (ET)
Jun 25, 2015 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001344413
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.28 | Jun 23, 2015 | A | 12,500 | A | — | Jun 22, 2025 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2015 Non-Employee Directors' Stock Award Plan (the "Plan"). 100% of the shares shall vest on the date of the next Annual Meeting of the Issuer's Stockholders, subject to the Reporting Person being a Non-Employee Director on such date. The option expires ten years after the date of grant, unless it expires sooner pursuant to the terms of the Plan.